Stock Analysis

Q-linea Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Published
OM:QLINEA

Q-linea (STO:QLINEA) Third Quarter 2024 Results

Key Financial Results

  • Net loss: kr42.4m (loss narrowed by 13% from 3Q 2023).
  • kr0.36 loss per share (improved from kr0.56 loss in 3Q 2023).
OM:QLINEA Earnings and Revenue History November 6th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Q-linea EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 79%. Earnings per share (EPS) exceeded analyst estimates by 10%.

Looking ahead, revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's shares are down 22% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 5 warning signs for Q-linea (2 are potentially serious!) that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Q-linea might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.